| Title |
Hope vs hype: where are we in type 1 diabetes?
|
|---|---|
| Published in |
Diabetologia, December 2017
|
| DOI | 10.1007/s00125-017-4530-x |
| Pubmed ID | |
| Authors |
Jay S. Skyler |
| Abstract |
Much progress has been made in type 1 diabetes research. Biological replacement of islet function has been achieved with pancreas transplantation and with islet transplantation. In the future, human embryonic stem cells and/or induced pluripotent stem cells may offer a potentially unlimited source of cells for islet replacement. Another potential strategy is to induce robust beta cell replication so that regeneration of islets can be achieved. Immune interventions are being studied with the hope of arresting the type 1 diabetes disease process to either prevent the disease or help preserve beta cell function. Mechanical replacement of islet cell function involves the use of glucose sensor-controlled insulin infusion systems. As all of these avenues are pursued, headlines often overstate the case, thus hyping any given advance, which provides enormous hope for patients and families seeking a cure for type 1 diabetes. Often, however, it is an animal study or a pilot trial that is being described. The reality is that translation to successful trials in human beings may not be readily achievable. This article discusses both the hype and the hopes in type 1 diabetes research. |
X Demographics
The data shown below were collected from the profiles of 50 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 9 | 18% |
| Spain | 5 | 10% |
| United States | 4 | 8% |
| Canada | 4 | 8% |
| Australia | 3 | 6% |
| Denmark | 2 | 4% |
| Germany | 2 | 4% |
| Austria | 1 | 2% |
| Netherlands | 1 | 2% |
| Other | 4 | 8% |
| Unknown | 15 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 27 | 54% |
| Scientists | 14 | 28% |
| Practitioners (doctors, other healthcare professionals) | 8 | 16% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 119 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 13% |
| Student > Ph. D. Student | 15 | 13% |
| Student > Master | 15 | 13% |
| Student > Bachelor | 11 | 9% |
| Student > Doctoral Student | 8 | 7% |
| Other | 19 | 16% |
| Unknown | 35 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 24% |
| Biochemistry, Genetics and Molecular Biology | 21 | 18% |
| Agricultural and Biological Sciences | 6 | 5% |
| Immunology and Microbiology | 5 | 4% |
| Engineering | 4 | 3% |
| Other | 15 | 13% |
| Unknown | 39 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2019.
All research outputs
#1,077,769
of 25,732,188 outputs
Outputs from Diabetologia
#550
of 5,376 outputs
Outputs of similar age
#24,183
of 450,473 outputs
Outputs of similar age from Diabetologia
#17
of 63 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,376 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.7. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,473 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.